首页> 外文学位 >Characterization of sustained-release formulations of inhaled rifampin for tuberculosis therapy.
【24h】

Characterization of sustained-release formulations of inhaled rifampin for tuberculosis therapy.

机译:用于肺结核治疗的吸入性利福平缓释制剂的表征。

获取原文
获取原文并翻译 | 示例

摘要

Tuberculosis (TB) is an infectious pulmonary disease and is considered to be the primary cause of death due to a single microorganism. Although current therapeutic interventions for the treatment of TB are effective, they are associated with a variety of medical complications such as rash, fever, gastrointestinal disturbances, and nervous system related symptoms. These complications can be explained, in part, on the basis of higher systemic exposure of the drugs used to treat TB. One of the ways to increase the efficacy and duration of local effect is by administering the sustained release form of the drug. This would lead to eradication of the active bacteria in the lung macrophages and simultaneously reduce the drugs' systemic side effects.; This study proposed a strategy to improve the effectiveness in TB therapy by providing sustained inhalation drug delivery systems. Rifampin, one of the most widely used drugs for TB therapy, was chosen as a model drug. Two polymer based systems, nanothin coatings of polymer onto drug powder by Pulsed Laser Deposition (PLD) and conventional polymer based microspheres prepared by a standard spray-drying method were developed. The formulations were prepared using poly lactic acid (PLA) and its copolymer, poly lactic co-glycolic acid (PLGA). The PLD-coated formulations were prepared under 30 min-coating time while the spray-drying formulations were prepared using various amounts of polymers (10–95%). The chemical changes of the polymer after pulsed-laser ablation and spray-drying was investigated. Ablation of polymer by the PLD technique indicated a reduction in molecular weight (Mw) and the appearance of minor degradation products under high-energy density. On the other hand, neither changes in Mw nor the appearance of degradation products was observed after using the spray-drying process, although there was some modification in polymer tacticity. The release characteristics of the formulations, the particle-size distribution and the cytotoxicity in a murine alveolar macrophage cell line were also evaluated. Both preparations showed a reduction in the in vitro drug release although the microspheres were more versatile in controlling the release rate. Both techniques were comparable in the respirable fractions, mass median aerodynamic diameter (MMAD), and the lack of cytotoxicity in the cell culture model. The efficacy of the treatment in the TB-infected macrophages and the pharmacokinetic study of the formulations in rats were also performed. The treatment efficacy was significantly higher for the sustained-release formulation as compared to the free drug. The pharmacokinetic (PK) study showed that although polymer coated drug particles obtained after both coating procedures exhibited sustained drug release, the spray-drying technique was a superior method for prolonging the mean residence time of the drug in the lung.
机译:结核病(TB)是一种传染性肺部疾病,被认为是单一微生物导致的主要死亡原因。尽管当前用于治疗结核病的治疗措施是有效的,但它们与多种医学并发症有关,例如皮疹,发烧,胃肠道疾病和神经系统相关症状。这些并发症的部分原因可以归因于用于治疗结核病的药物的更高的全身暴露。增加效力和局部作用持续时间的方法之一是通过给药药物的持续释放形式。这将导致根除肺巨噬细胞中的活性细菌,同时减少药物的全身性副作用。这项研究提出了一种通过提供持续吸入药物输送系统来提高结核病治疗效果的策略。利福平是最广泛用于结核病治疗的药物之一,被选为模型药物。开发了两种基于聚合物的系统:通过脉冲激光沉积(PLD)在药物粉末上的聚合物纳米薄涂层和通过标准喷雾干燥法制备的常规基于聚合物的微球。使用聚乳酸(PLA)及其共聚物聚乳酸共乙醇酸(PLGA)制备制剂。 PLD涂层的配方是在30分钟的涂层时间下制备的,而喷雾干燥的配方是使用各种量的聚合物(10-95%)制备的。研究了脉冲激光烧蚀和喷雾干燥后聚合物的化学变化。通过PLD技术烧蚀聚合物表明在高能量密度下分子量(M w )降低并且出现了较小的降解产物。另一方面,尽管在聚合物立构规整度上有一些改变,但在使用喷雾干燥法后,没有观察到M 的变化或降解产物的出现。还评估了制剂的释放特性,在鼠肺泡巨噬细胞系中的粒度分布和细胞毒性。两种制剂均显示出体外药物释放的减少,尽管微球在控制释放速率方面更具通用性。两种技术在可呼吸分数,质量中位数空气动力学直径(MMAD)和细胞培养模型中缺乏细胞毒性方面具有可比性。还进行了在被TB感染的巨噬细胞中的治疗功效以及该制剂在大鼠中的药代动力学研究。与游离药物相比,缓释制剂的治疗功效明显更高。药代动力学(PK)研究表明,尽管在两次包衣步骤后获得的聚合物包衣的药物颗粒均显示出持续的药物释放,但喷雾干燥技术是延长药物在肺中平均停留时间的一种较好方法。

著录项

  • 作者

    Coowanitwong, Intira.;

  • 作者单位

    University of Florida.;

  • 授予单位 University of Florida.;
  • 学科 Health Sciences Pharmacy.
  • 学位 Ph.D.
  • 年度 2003
  • 页码 121 p.
  • 总页数 121
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药剂学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号